We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+28.85%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$117M
AUM Growth
+$5.01M
Cap. Flow
-$4.67M
Cap. Flow %
-3.97%
Top 10 Hldgs %
39.15%
Holding
85
New
22
Increased
25
Reduced
13
Closed
24

Sector Composition

Rank Sector Weight
1 Healthcare 36.91%
2 Industrials 12.76%
3 Communication Services 12.13%
4 Technology 6.3%
5 Materials 5.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SODA
76
PUT
DELISTED
SodaStream International Ltd
SODA
-12,700
Closed -$630K
CBI
77
DELISTED
Chicago Bridge & Iron Nv
CBI
-16,000
Closed -$1.33M
TMH
78
DELISTED
Team Health Holdings Inc
TMH
-22,500
Closed -$1.02M
MEG
79
DELISTED
Media General, Inc
MEG
-127,500
Closed -$2.88M
ZGNX
80
DELISTED
Zogenix, Inc.
ZGNX
-11,525
Closed -$317K
NPSP
81
DELISTED
NPS PHARMACEUTICALS INC
NPSP
-5,250
Closed -$159K
GENT
82
DELISTED
GENTIUM SPA ADS
GENT
-46,000
Closed -$2.63M
AIRM
83
DELISTED
Air Methods Corp
AIRM
-11,000
Closed -$641K
LNKD
84
DELISTED
LinkedIn Corporation
LNKD
-11,500
Closed -$2.49M
MDVN
85
DELISTED
MEDIVATION, INC.
MDVN
-66,000
Closed -$2.11M

Similar funds

Atika Capital Management's Q1 2014 Portfolio in Review

As of Q1 2014, Atika Capital Management held 85 positions worth $117M, up 4.5% from $112M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Atika Capital Management withdrew a net $4.67M in Q1 2014, closing 24 positions and reducing 13 holdings. Its most notable exit was Gilead Sciences, an estimated $3.91M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 28% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Atika Capital Management opened a new position in Biogen worth $2.6M.

  • Atika Capital Management's largest Q1 2014 buy was Biogen: 8,500 shares worth $2.6M.
  • Atika Capital Management added most to Incyte in Q1 2014, an estimated $2.45M increase.
  • Atika Capital Management's biggest Q1 2014 reduction was Netflix, cutting an estimated $2.41M.
  • Atika Capital Management fully exited Gilead Sciences in Q1 2014, selling an estimated $3.91M.
  • Atika Capital Management's ten largest holdings make up 39% of its $117M portfolio in Q1 2014.
  • Atika Capital Management opened 22 new positions and closed 24 in Q1 2014.
  • Atika Capital Management's portfolio value rose 4.5% quarter-over-quarter to $117M.

Based on Atika Capital Management's 13F filing for Q1 2014, filed 15 May 2014.